HeartBeam (BEAT)
(Delayed Data from NSDQ)
$2.30 USD
-0.06 (-2.54%)
Updated Nov 13, 2024 04:00 PM ET
After-Market: $2.30 0.00 (0.00%) 5:10 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$2.30 USD
-0.06 (-2.54%)
Updated Nov 13, 2024 04:00 PM ET
After-Market: $2.30 0.00 (0.00%) 5:10 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Advisory Board (ABCO) in Focus: Stock Moves 6.4% Higher
by Zacks Equity Research
Advisory Board (ABCO) shares rose more than 6% in the last trading session, amid huge volumes.
Why Biotelemetry (BEAT) Could Be an Impressive Growth Stock
by Zacks Equity Research
Biotelemetry (BEAT) seems well-positioned for future earnings growth and it is seeing rising earnings estimates as well, coupled with a solid Zacks Rank.
The Zacks Analyst Blog Highlights: Health Insurance Innovations, BioTelemetry, Solaredge Technologies, Aaron's and Petmed Express
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Health Insurance Innovations, BioTelemetry, Solaredge Technologies, Aaron's and Petmed Express
Here's Why Investors Should Buy BioTelemetry (BEAT) Now
by Zacks Equity Research
BioTelemetry's (BEAT) buyout of LifeWatch AG has expanded its product portfolio and customer base in the cardiac monitoring and diagnostic services space.
BioTelemetry Hits a 52-Week High: What's Driving the Stock?
by Zacks Equity Research
BioTelemetry (BEAT) is putting efforts in product innovation through research and development. The company recently announced the acquisition of LifeWatch AG in a deal valued at about $280 million.
New Strong Buy Stocks for August 16th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday
Top Ranked Momentum Stocks to Buy for August 16th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, August 16th:
BioTelemetry (BEAT) Q2 Earnings Top, Revenues Meet Estimates
by Zacks Equity Research
BioTelemetry (BEAT) rides high on all its segments in Q2. The company is also putting in efforts in product innovation through research and development.
BioTelemetry (BEAT) Acquires LifeWatch for $280 Million
by Zacks Equity Research
BioTelemetry Inc. (BEAT) enhances its position in the wireless medicine space, enlarges product profile and customer base in cardiac monitoring and diagnostic services with LifeWatch buyout.
BioTelemetry, Inc. (BEAT) in Focus: Stock Moves 6.5% Higher
by Zacks Equity Research
BioTelemetry (BEAT) was a big mover last session, as the company saw its rise nearly 7% on Friday amid huge volumes.
Will BioTelemetry (BEAT) Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in BioTelemetry, Inc. (BEAT).
BioTelemetry (BEAT) Shows Strength: Stock Moves 8.8% Higher
by Zacks Equity Research
BioTelemetry, Inc. (BEAT) shares rose almost 9% in the last trading session.
This Week's Hidden Gems: (AAOI)(BEAT)
by Patrick Anderson
Tracey Ryniec uncovers two top stocks that are flying under the radar.
Teladoc Continues to Grow in Booming Telehealth Industry
by Zacks Equity Research
Teladoc Inc. (TDOC), a premier telehealth services provider, is rapidly expanding its business in the booming telehealth services industry.
The Zacks Analyst Blog Highlights: BioTelemetry, WellCare Health Plans, Joint, HCA Holdings and Chemed
by Zacks Equity Research
The Zacks Analyst Blog Highlights: BioTelemetry, WellCare Health Plans, Joint, HCA Holdings and Chemed
5 Stocks to Buy for the Post-Obamacare Era
by Swarup Gupta
Insurers, hospitals and healthcare service providers with strong fundamentals would make welcome additions to your portfolio.
BioTelemetry (BEAT) Looks Good: Stock Adds 7.2% in Session
by Zacks Equity Research
BioTelemetry, Inc. (BEAT) saw its shares rise above 7% in the last trading session.
New Strong Buy Stocks for February 24th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
New Strong Buy Stocks for August 11th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
New Strong Buy Stocks for August 9th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
5 Strong Stocks in Stronger Industries
by David Bartosiak
The market rewards strength. These are the best stocks in the best industries.
Top 5 Medical Service Stocks to Buy
by Brian Hamilton
The Medical sector is one of the top performing sectors for Q3 2015, and it is expected to be a top performer in Q4 2015 too.
Two Perfectly Timed Momentum Stock Trades
by David Bartosiak
These two stock ideas are showing up at the perfect time to buy.
5 Top Performing Stocks to Buy
by David Bartosiak
If a stock can perform in this market, imagine how it will do when things normal out